drugset / Trial / NCT05293522

A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair.

NCT05293522 ↗

Phase 2 Terminated 2 enrolled Neuraptive Therapeutics Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

This study involves the use of an Investigational Product called NTX-001. It is a product used in the repair of nerve injuries. It is used in the operating room. The main purposes of this study are to 1) see how safe NTX-001 is when used in nerve repair and, 2) see if your nerve becomes functional in a shorter period of time when compared to what is normally done to treat nerve injuries.

Timeline

Start
2022-07-12
Primary completion
2023-08-22
Completion
2023-08-22

Outcome

Outcome not reported

Stopped (Enrollment): “Enrollment Rate”

Drugs

EvaluationDrugModalityDoseRoute
Subject NTX-001 Unknown — —

Indications